Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation - NCT00412984-Novosibirsk - 00684 (Clinical Trial 158506)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy158506.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please search our studies.
|
|
 |
 |
|
| City: |
|
Novosibirsk |
|
Country:
|
|
Russian Federation |
|
|
|
| Conditions: |
|
Atrial Fibrillation - Atrial Flutter |
| Purpose: |
|
The trial seeks to determine if apixaban, an investigational anticoagulant (blood-thinner) is
as effective as standard therapy (warfarin) in preventing stroke and systemic embolism in
subjects with atrial fibrillation and risk factors for stroke.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Males and females ≥ 18 yrs with AF and one or more of the following risk factors for
stroke:
- Age ≥ 75, previous stroke
- TIA or Systemic Embolism
- Symptomatic congestive heart failure or left ventricular dysfunction with LVEF ≤ 40%
- Diabetes mellitus or hypertension requiring pharmacological treatment |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
September 1, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|